[1]中华医学会肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) ∶56.
|
[2]郑志雄.凝血酶原活动度变化在重症肝炎与肝硬化失代偿期的意义对比[J].广东医学, 2002, 23 (5) ∶516.
|
[3]叶维法, 钟振义.肝胆病诊断学[M].天津:天津科学技术出版社, 1997∶145-146.
|
[1] | Lu: RiYing, Wu JiZhou. Risk factors of hepatorenal syndrome in patients with severe hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(7): 542-544. |
[3] | Zhang WeiWei, Yuan XueHua, Tan HuaBing, Zhan GuoQing, Li RuGui, Du WeiXing. Therapeutic Efficacy of telbivudine with phentolamine on patients with chronic severe hepatits B[J]. Journal of Clinical Hepatology, 2009, 25(6): 418-419. |
[4] | Zhan GuoQing, Zheng SanJu, Zhu Lin, Jiang Shan. The clinical analysis on factors influencing the prognosis of severe hepatitis in 365 cases.[J]. Journal of Clinical Hepatology, 2008, 24(4): 251-253. |
[6] | Zhang FenMing, Gao SuQin. Clinical research of joint system of artificial liver support on treating patients with severe viral hepatitis B[J]. Journal of Clinical Hepatology, 2007, 23(2): 107-109. |
[9] | Gao HongBo, Xu Min, Hu XiaoBing, Li YuePing. The changes and significance of T-lymphocytes subsets in severe hepatitis patients.[J]. Journal of Clinical Hepatology, 2006, 22(3): 175-176. |
[15] | Zhang JiWan, Wang HaiBin, Zhou JianLi, Liu TongFa, He PengFei, Wang YeDong, Zhang HaiLing, Long Li, Wang BinRong. Relationship between the serum complement receptor 1 of patients with hepatitis gravis and the degree of liver damage[J]. Journal of Clinical Hepatology, 2003, 19(3): 174-175. |
[16] | Ding QiaoYun, Zhang HanRong. Lamivudine therapy in chronic hepatitis B causing severe hepatitis.[J]. Journal of Clinical Hepatology, 2003, 19(6): 351-352. |